Quotes 5-day view Delayed Japan Exchange
07/01/2022
07/04/2022
07/05/2022
07/06/2022
07/07/2022
Date
4013(c)
4062(c)
4100(c)
4099(c)
4212
Last
1 624 400
1 034 600
1 271 500
1 706 500
1 350 500
Volume
-1.83%
+1.22%
+0.94%
-0.02%
+2.76%
Change
Estimated financial data (e) JPY USD
Sales 2023
774 B
5 701 M
5 701 M
Net income 2023
102 B
750 M
750 M
Net cash position 2023
19 453 M
143 M
143 M
P/E ratio 2023
30,2x
Yield 2023
0,90%
Sales 2024
829 B
6 108 M
6 108 M
Net income 2024
117 B
864 M
864 M
Net cash position 2024
82 714 M
609 M
609 M
P/E ratio 2024
26,1x
Yield 2024
0,98%
Capitalization
3 100 B
22 832 M
22 832 M
EV / Sales 2023
3,98x
EV / Sales 2024
3,64x
Nbr of Employees
28 294
Free-Float
95,3%
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments...
Ratings of Terumo Corporation
All news about TERUMO CORPORATION
News in other languages on TERUMO CORPORATION
Analyst Recommendations on TERUMO CORPORATION
TERUMO CORPORATION - 2021
Big comeback of buyers
BUY
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends TERUMO CORPORATION
Short Term Mid-Term Long Term Trends Neutral Neutral Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4 099,00 JPY
Average target price
5 037,14 JPY
Spread / Average Target
22,9%
Please enable JavaScript in your browser's settings to use dynamic charts.